Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
0.82Price to Book
VS
Market
Sector
Industry
History
$ 9.16Close
$ 4.26 - $ 11.97 52-Week Range
Ticker Information
Ticker
EBSCompany Name
EMERGENT BIOSOLUTIONS INCSector
HealthcareIndustry
Drug Manufacturers - Specialty & GenericExchange
NYSEEMERGENT BIOSOLUTIONS INC - Price to Book Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
EBS - P/B Historical data
| Date | Shareholders Equity | Market Capitalization | Price to Book |
|---|---|---|---|
| 6/30/2025 | $ 536.2M | $ 439.61M | 0.82 |
| 3/31/2025 | $ 552.7M | $ 345.21M | 0.62 |
| 12/31/2024 | $ 482.8M | $ 347.21M | 0.72 |
| 9/30/2024 | $ 508.4M | $ 596.03M | 1.17 |
| 6/30/2024 | $ 386.3M | $ 302.63M | 0.78 |
| 3/31/2024 | $ 663.9M | $ 172.93M | 0.26 |
| 12/31/2023 | $ 649.3M | $ 140.43M | 0.22 |
| 9/30/2023 | $ 697.2M | $ 109.99M | 0.16 |
| 6/30/2023 | $ 956.3M | $ 306.7M | 0.32 |
| 3/31/2023 | $ 1.2B | $ 545.34M | 0.45 |
Key Performance Insights, Last 5 Years
- EMERGENT BIOSOLUTIONS INC's latest trailing twelve months (TTM) P/B stands at 3.91.
- Over the past 5 years, EMERGENT BIOSOLUTIONS INC's average P/B has been 1.15.
- The median P/B for EMERGENT BIOSOLUTIONS INC during this period was 0.8
- EMERGENT BIOSOLUTIONS INC reached its highest P/B over the past 5 years at 3.91.
- The lowest P/B recorded by EMERGENT BIOSOLUTIONS INC in the same timeframe 0.16
EMERGENT BIOSOLUTIONS INC's P/B vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
P/B Benchmarks
Similar metrics to P/B:
- Price to Sales - [Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Shareholders Equity - [Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.
Definition of Price to Book
[Calculation] Measures a company’s [MarketCap] in relation to its [Equity] which is the value of [Assets] minus [Liabilities].Market Cap / Equity
(=) P/B P/B for EMERGENT BIOSOLUTIONS INC is calculated as follows: Market Cap [ $ 4.89B ] / Equity [ $ 1.25B ]
(=) P/B [ 3.91 ] EBS - Price to Book, Last 5 years
0.16
Minimum
Sep 30, 2023
3.91
Maximum
Sep 30, 2020
1.15
Average
0.8
Median
P/B Benchmark AnalysisMarket
The chart above depicts the distribution of P/B for companies in the Total Stock Market. The average P/B of the companies is 2.29 with a standard deviation of 1.81.
The following table provides additional summary stats:
P/B in the Market:
| filtered constituents | 3.36K |
|---|---|
| min | 0 |
| max | 8.04 |
| average | 2.29 |
| median | 1.63 |
| std | 1.81 |